Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT06133569
Recruiting Not applicable

ReDirection - Self Help Program for Individuals with Sexual Interest in Children

NCT06133569 · tracked via the Priya Life Science Spain tracker
Sponsor
Karolinska Institutet
Phase
Not applicable
Started
2023-09-27
Last updated
2024-10-10

Condition(s) studied

Child Abuse SexualPedophilia

Investigational drug(s) / intervention(s)

ReDirection

ReDirection: Self help program based on principles for cognitive behavioral therapy

Study summary

The overall aim of the study is to evaluate the effectiveness of the ReDirection program for individuals with low or medium risk to commit child sexual abuse.

Primary question: Is ReDirection a feasible, effective, and safe method in reducing low to medium risk participants' use of CSAM and related behaviors?

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Sufficient language skills: English, Swedish, Finnish, Czech, Slovak, German, or Spanish * concern about sexual interest regarding children\*, * CSAM use past six month * Low to medium risk for committing child sexual abuse according to the SChiMRA scale Exclusion Criteria: \- Participants with a severe psychiatric illness (such as high acute suicide risk or severe substance abuse) will be excluded, or lack of serious intentions to participate.

Primary outcome measure(s)

  • Sexual interest involving children — Pre-intervention, during the intervention, and immediately after the intervention.
    Measured by Sexual Symptom Assessment Scale (SASS)(0-48 points; higher scores indicate more interest).
  • Child sexual abuse material usage — Pre-intervention, during the intervention, and immediately after the intervention.
    Measured with Sexual Child Molestation Risk Assessment (SChiMRA+), part B, item 1 (self-reported time spent last week in hours watching CSAM) including 3 follow up questions (about time/day, severity, and of youngest child).
  • Other behaviors related to sexual interest in children. — Pre-intervention, during the intervention, and immediately after the intervention.
    Time spent last week (hours), as self reported on the SChiMRA+ scale part B, item 4.
  • Depressive symtoms — Pre-intervention, and immediately after the intervention.
    Scores on the PHQ-9 questionnaire (Patient Health Questionnaire; 0-27 points; higher scores indicate more severe depressive symptoms).

Trial sites (6)

FacilityCityRegionStatus
National Institute of Mental Health Klecany Czechia Recruiting
Protect Children NGO Helsinki Finland Recruiting
[University Medical Center Hamburg-Eppendorf Hamburg Germany Recruiting
Bratislava Police Academy Bratislava Slovakia Recruiting
Universitat Jaume I Castelló Spain Recruiting
Centre for psychiatry research, Region Stockholm Stockholm Sweden Recruiting

More Karolinska Institutet trials in Spain

Prehospital Resuscitation Intranasal Cooling Effectiveness Survival Study 2 Recruiting
Mi Bridge - Motivational Interviewing to Facilitate Help-seeking Among Individuals with Sexual Interest in Children Recruiting
Overweight and Obesity in Preschoolers Active, not recruiting

Other trials for the same condition

Mi Bridge - Motivational Interviewing to Facilitate Help-seeking Among Individuals with Sexual Interest in Children Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06133569 on ClinicalTrials.gov ↗ ← All trials in Spain